-DOCSTART- -X- O
Prevention -X- _ O
of -X- _ O
serious -X- _ O
infections -X- _ O
in -X- _ O
pregnant -X- _ B-Patient
mothers -X- _ I-Patient
, -X- _ O
newborns -X- _ B-Patient
, -X- _ O
and -X- _ O
young -X- _ B-Patient
infants -X- _ I-Patient
through -X- _ O
immunization -X- _ B-Intervention
during -X- _ I-Intervention
pregnancy -X- _ I-Intervention
and -X- _ I-Intervention
in -X- _ I-Intervention
early -X- _ I-Intervention
life -X- _ I-Intervention
has -X- _ O
the -X- _ O
potential -X- _ O
to -X- _ O
further -X- _ O
reduce -X- _ O
maternal -X- _ B-Outcome
and -X- _ I-Outcome
neonatal -X- _ I-Outcome
morbidity -X- _ I-Outcome
and -X- _ I-Outcome
mortality -X- _ I-Outcome
worldwide. -X- _ I-Outcome
In -X- _ O
the -X- _ O
past -X- _ O
decade -X- _ O
, -X- _ O
research -X- _ O
in -X- _ O
this -X- _ O
field -X- _ O
has -X- _ O
advanced -X- _ O
substantially -X- _ O
, -X- _ O
from -X- _ O
the -X- _ O
understanding -X- _ O
of -X- _ O
the -X- _ O
biology -X- _ O
and -X- _ O
immunology -X- _ O
of -X- _ O
pregnancy -X- _ O
and -X- _ O
early -X- _ O
life -X- _ O
, -X- _ O
to -X- _ O
the -X- _ O
active -X- _ O
development -X- _ O
of -X- _ O
several -X- _ O
candidate -X- _ O
vaccines -X- _ O
, -X- _ O
for -X- _ O
which -X- _ O
challenges -X- _ O
and -X- _ O
opportunities -X- _ O
for -X- _ O
global -X- _ O
implementation -X- _ O
are -X- _ O
under -X- _ O
consideration. -X- _ O
Experts -X- _ O
from -X- _ O
academia -X- _ O
, -X- _ O
industry -X- _ O
, -X- _ O
regulatory -X- _ O
and -X- _ O
funding -X- _ O
agencies -X- _ O
, -X- _ O
public -X- _ O
health -X- _ O
, -X- _ O
and -X- _ O
international -X- _ O
organizations -X- _ O
met -X- _ O
in -X- _ O
Brussels -X- _ O
( -X- _ O
Belgium -X- _ O
) -X- _ O
from -X- _ O
10 -X- _ O
to -X- _ O
12 -X- _ O
September -X- _ O
2017 -X- _ O
, -X- _ O
at -X- _ O
the -X- _ O
4th -X- _ O
International -X- _ O
Neonatal -X- _ O
and -X- _ O
Maternal -X- _ O
Immunization -X- _ O
Symposium -X- _ O
( -X- _ O
INMIS -X- _ O
) -X- _ O
, -X- _ O
to -X- _ O
review -X- _ O
the -X- _ O
most -X- _ O
relevant -X- _ O
advances -X- _ O
in -X- _ O
maternal -X- _ O
and -X- _ O
neonatal -X- _ O
immunization. -X- _ O
The -X- _ O
overarching -X- _ O
focus -X- _ O
of -X- _ O
the -X- _ O
conference -X- _ O
was -X- _ O
to -X- _ O
identify -X- _ O
the -X- _ O
path -X- _ O
forward -X- _ O
to -X- _ O
achieve -X- _ O
integration -X- _ O
of -X- _ O
maternal -X- _ O
and -X- _ O
early -X- _ O
life -X- _ O
immunization -X- _ O
strategies -X- _ O
for -X- _ O
the -X- _ O
successful -X- _ O
implementation -X- _ O
of -X- _ O
vaccines -X- _ O
in -X- _ O
antenatal -X- _ O
care -X- _ O
and -X- _ O
pediatric -X- _ O
programs -X- _ O
for -X- _ O
reduction -X- _ B-Outcome
of -X- _ I-Outcome
maternal -X- _ I-Outcome
and -X- _ I-Outcome
infant -X- _ I-Outcome
mortality -X- _ I-Outcome
worldwide. -X- _ I-Outcome
IMPORTANCE -X- _ O
This -X- _ O
report -X- _ O
provides -X- _ O
an -X- _ O
overview -X- _ O
of -X- _ O
the -X- _ O
proceedings -X- _ O
of -X- _ O
the -X- _ O
4th -X- _ O
International -X- _ O
Maternal -X- _ O
and -X- _ O
Neonatal -X- _ O
Immunization -X- _ O
Symposium -X- _ O
, -X- _ O
where -X- _ O
presentations -X- _ O
focused -X- _ O
on -X- _ O
the -X- _ O
state-of-the-art -X- _ O
research -X- _ O
on -X- _ O
the -X- _ O
development -X- _ O
and -X- _ O
implementation -X- _ O
of -X- _ O
vaccines -X- _ B-Intervention
given -X- _ I-Intervention
during -X- _ I-Intervention
pregnancy -X- _ I-Intervention
for -X- _ I-Intervention
the -X- _ I-Intervention
protection -X- _ I-Intervention
of -X- _ I-Intervention
mothers -X- _ I-Intervention
and -X- _ I-Intervention
infants -X- _ I-Intervention
. -X- _ O

